<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209427</url>
  </required_header>
  <id_info>
    <org_study_id>17100209</org_study_id>
    <nct_id>NCT03209427</nct_id>
  </id_info>
  <brief_title>Serum Serotonin and Pruritus After Intrathecal Morphine in Cesarean Section</brief_title>
  <official_title>Pruritus After Intrathecal Morphine in Cesarean Section: Incidence, Severity and Its Relation to Serum Serotonin Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pruritus is the commonest side effect of intrathecal morphine especially in parturient, but
      the exact mechanism of pruritus is not clear. Many mechanisms have been suggested. Among
      these mechanisms is the activation of the 5-HT3 receptors by the intrathecally injected
      morphine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty parturients underwent elective cesarean section under spinal anesthesia were divided
      into two groups of 20 each in this prospective randomized study. Group I received 100 µg of
      intrathecal morphine (ITM) mixed with 12 mg of 0.5% heavy bupivacaine (M100) while group II
      received 200 µg of ITM mixed with 12 mg of 0.5% heavy bupivacaine (M200). Two blood samples
      were taken from each patient for serotonin estimation, preoperatively and 4 hrs later.
      Postoperatively all patients were assessed for pruritus (incidence &amp; severity), visual analog
      scale (VAS), first request of analgesia, and total analgesic dose required within 24 hrs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2014</start_date>
  <completion_date type="Actual">September 21, 2016</completion_date>
  <primary_completion_date type="Actual">April 30, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pruritus</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>incidence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pruritus</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serotonin</measure>
    <time_frame>preoperative</time_frame>
    <description>Serum level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serotonin</measure>
    <time_frame>4 hours postoperative</time_frame>
    <description>Serum level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pruritus</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal injection of 100 μg morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>iIntrathecal injection of 200 μg morphine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 100 μg</intervention_name>
    <description>Intrathecal injection of morphine100 μg</description>
    <arm_group_label>Group I</arm_group_label>
    <other_name>M100</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 200 μg</intervention_name>
    <description>Intrathecal injection of morphine 200 μg</description>
    <arm_group_label>Group II</arm_group_label>
    <other_name>M200</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I - II term pregnant patients scheduled for elective cesarean section

        Exclusion Criteria:

          -  patients with a known allergy to the study drugs

          -  significant cardiac, respiratory, renal, neurological, or hepatic disease;
             -coagulation disorders

          -  BMI &gt; 30 kg/m2

          -  any itchy skin diseases.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed G Aly, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut university faculty of medicine</affiliation>
  </overall_official>
  <results_reference>
    <citation>Bonnet MP, Marret E, Josserand J, Mercier FJ. Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review. Br J Anaesth. 2008 Sep;101(3):311-9. doi: 10.1093/bja/aen202. Epub 2008 Jul 7. Review.</citation>
    <PMID>18611915</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>July 4, 2017</last_update_submitted>
  <last_update_submitted_qc>July 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed galal aly</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>morphine, pruritus, serotonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Serotonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

